Company Filing History:
9 out of 531 
2 out of 75 Years Active: 2002-2023
Title: The Innovative Contributions of Jean Stephenne
Introduction
Jean Stephenne is a notable inventor based in Rixensart, Belgium. He has made significant contributions to the field of immunology, particularly in the development of influenza vaccines. With a total of 11 patents to his name, his work has had a profound impact on public health.
Latest Patents
Among his latest patents is a monovalent influenza vaccine formulation. This invention relates to vaccination regimes aimed at immunizing against influenza disease. It focuses on augmenting immune responses to various antigens and outlines methods of preparation. The monovalent influenza immunogenic compositions comprise an influenza antigen from a virus strain associated with a pandemic outbreak. This formulation is combined with an oil-in-water emulsion adjuvant that includes a metabolisable oil, a sterol, and/or a tocopherol, such as alpha tocopherol, along with an emulsifying agent.
Career Highlights
Jean Stephenne has had a distinguished career, working with prominent companies in the pharmaceutical industry. He has been associated with GlaxoSmithKline Biologicals SA and SmithKline Beecham Biologicals S.A. His expertise in vaccine development has positioned him as a key figure in the field.
Collaborations
Throughout his career, Jean has collaborated with esteemed colleagues, including Emmanuel Jules Hanon and Martine Anne Cecile Wettendorff. These collaborations have further enhanced his contributions to vaccine research and development.
Conclusion
Jean Stephenne's innovative work in the field of influenza vaccines exemplifies the importance of research and development in public health. His numerous patents and collaborations highlight his commitment to advancing medical science.